An open phase III trial with Letrozole (Femara®) as Early Adjuvant treatment of postmenopausal patients with primary breast cancer

Update Il y a 4 ans
Reference: EUCTR2004-003889-15

Woman Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

It is the aim of this prospective one arm phase III clinical study to evaluate recurrence in postmenopausal patients with breast cancer during 24 months of Letrozole treatment. · Rate of patients without recurrence after 24 months of Letrozole treatment.


Inclusion criteria

  • Primary breast cancer in postmenopausal patients

Links